Posts

Loan Facility for Canary Medical Horizon Technology Finance and Silicon Valley Bank Provide $20 Million Venture

/in

Link to Full Article FARMINGTON, Conn., Jan. 4, 2021 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, along with lending partner, Silicon Valley Bank (“SVB”), a provider […]

Read more

NICE Publishes Briefing on Saluda’s Evoke Closed-Loop Spinal Cord Stimulation (SCS) System

/in

Link to Full Article Artarmon, Australia – December 22, 2020 – Saluda Medical Pty Limited (“Saluda Medical”) announced today that the UK’s National Institute for Health and Care Excellence (NICE) issued a Medtech Innovation Briefing (MIB) titled “Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain.” The MIB states Evoke would be used as a […]

Read more

Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer

/in

Link to Full Article Strengthens corporate leadership as company moves toward global commercialization Artarmon, Australia – June 9, 2020 – Saluda Medical Pty Limited (“Saluda Medical”), a global neuromodulation company leading the development and commercialization of data-driven, personalized therapies for patients with debilitating neurological disorders, today announced the key leadership appointments of Jim Schuermann as President and Robert Gaffney as Chief Operating […]

Read more

Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

/in

Link to Full Article ARTARMON, NSW, Australia, January 21, 2020 – Saluda Medical Pty Limited (“Saluda Medical”) today announced that data from multiple studies evaluating the company’s Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain will be featured in multiple presentations – including eight oral presentations and award of Best Clinical Abstract – during […]

Read more

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

/in

Link to Full Article ARTARMON , Australia, Dec. 20, 2019 /PRNewswire/ — Saluda Medical Pty Limited (“Saluda Medical”) today announced The Lancet Neurology journal published results from the U.S. Pivotal Study demonstrating its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System provided long-term, statistically superior, and clinically meaningful pain relief for patients with chronic intractable back and leg pain out […]

Read more

PKG Wristwatch Device May Improve Clinical Decision-Making in Parkinson’s, Study Shows

/in

Link to Full Article Overall, the device provided information for better treatment plans, allowed doctors to assess the efficacy of treatments, and improved doctor-patient communication. The findings were reported in “PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson’s Disease,” a study published in the journal Frontiers in Neurology. The […]

Read more

Regulatory approval next hurdle for Saluda Medical

/in

Link to Full Article Regulatory approval is the next major hurdle facing Saluda Medical, the biotech company which is led Cochlear’s former chief technology officer and was responsible for the biggest domestic life sciences capital raising of the last fiscal year. Saluda Medical said in June it had raised $US75 million ($106 million) from […]

Read more

Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients

/in

Link to Full Article Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH, NH USA, LONDON, UK and MELBOURNE, Australia, July 23, 2019 – Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use […]

Read more

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group

/in

Artarmon, NSW, Australia – June 28, 2019 – Saluda Medical Pty Limited (“Saluda Medical”) today announced that it has secured $75 million in equity financing from Boston Scientific Corporation (NYSE: BSX) and Redmile Group LLC to fund the final stages of development through commercialization of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for […]

Read more

Saluda Medical Secures Debt Financing From Medtronic

/in

Proceeds to fund continued development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. Pivotal Study in SCS Proceeds to fund continued development of Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System Evoke Trial Validates Level I Evidence Achieved Through First Double-Blind Randomized U.S. […]

Read more